Maze Therapeutics is a clinical-stage biopharmaceutical company developing novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases.
Lead the clinical development strategy for Maze Therapeutics' APOL1 program and other early-stage clinical assets. Design and oversee clinical trials, guide cross-functional teams, and engage with scientific thought leaders and patient advocacy groups.
Maze Therapeutics is a clinical-stage biopharmaceutical company developing novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases.
Maze Therapeutics